Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: A population-based cohort study

L. Ban, J. E. Gibson, J. West, L. Fiaschi, R. Sokal, L. Smeeth, P. Doyle, R. B. Hubbard, L. J. Tata

Research output: Journal PublicationArticlepeer-review

66 Citations (Scopus)

Abstract

Objective: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions.

Design: Population-based cohort study.

Setting: Linked UK maternal-child primary care records.

Population: A total of 349 127 singletons liveborn between 1990 and 2009.

Methods: Odds ratios adjusted for maternal sociodemographics and comorbidities (aORs) were calculated for MCAs, comparing women with first-trimester selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) and women with diagnosed but unmedicated depression, or women without diagnosed depression.

Main: outcome measures Fourteen system-specific MCA groups classified according to the European Surveillance of Congenital Anomalies and five specific heart anomaly groups.

Results: Absolute risks of MCA were 2.7% (95% confidence interval, 95% CI, 2.6-2.8%) in children of mothers without diagnosed depression, 2.8% (95% CI 2.5-3.2%) in children of mothers with unmedicated depression, and 2.7% (95% CI 2.2-3.2%) and 3.1% (95% CI 2.2-4.1%) in children of mothers with SSRIs or TCAs, respectively. Compared with women without depression, MCA overall was not associated with unmedicated depression (aOR 1.07, 95% CI 0.96-1.18), SSRIs (aOR 1.01, 95% CI 0.88-1.17), or TCAs (aOR 1.09, 95% CI 0.87-1.38). Paroxetine was associated with increased heart anomalies (absolute risk 1.4% in the exposed group compared with 0.8% in women without depression; aOR 1.78, 95% CI 1.09-2.88), which decreased marginally when compared with women with diagnosed but unmedicated depression (aOR 1.67, 95% CI 1.00-2.80).

Conclusions: Overall MCA risk did not increase with maternal depression or with antidepressant prescriptions. Paroxetine was associated with increases of heart anomalies, although this could represent a chance finding from a large number of comparisons undertaken.

Original languageEnglish
Pages (from-to)1471-1481
Number of pages11
JournalBJOG: An International Journal of Obstetrics and Gynaecology
Volume121
Issue number12
DOIs
Publication statusPublished - 1 Nov 2014
Externally publishedYes

Keywords

  • Antidepressants
  • Congenital anomaly
  • Depression
  • SSRIs
  • TCAs

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Fingerprint

Dive into the research topics of 'Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: A population-based cohort study'. Together they form a unique fingerprint.

Cite this